FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Demski David M 2. Issuer Name and Ticker or Trading Symbol GLOBUS MEDICAL INC [ GMED ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
President, CEO
(Last)         (First)         (Middle)
VALLEY FORGE BUSINESS CENTER, 2560 GENERAL ARMISTEAD AVENUE
3. Date of Earliest Transaction (MM/DD/YYYY)
4/23/2021
(Street)
AUDUBON, PA 19403
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock  4/23/2021    M    21875  A $43.77  21875  D   
Class A Common Stock  4/23/2021    M    21875  A $43.58  43750  D   
Class A Common Stock  4/23/2021    M    22821  A $29.31  66571  D   
Class A Common Stock  4/23/2021    M    54688  A $53.27  121259  D   
Class A Common Stock  4/23/2021    S(1)    121259  D $71.59 (2) 0  D   
Class A Common Stock  4/26/2021    M    78334  A $26.27  78334  D   
Class A Common Stock  4/26/2021    M    65929  A $29.31  144263  D   
Class A Common Stock  4/26/2021    S(1)    144263  D $71.50 (3) 0  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)  $43.77  4/23/2021    M        21875    (4) 1/22/2028  Class A Common Stock  21875  $0.00  28125  D   
Stock Option (Right to Buy Class A Common Stock)  $43.58  4/23/2021    M        21875    (5) 1/22/2029  Class A Common Stock  21875  $0.00  65625  D   
Stock Option (Right to Buy Class A Common Stock)  $29.31  4/23/2021    M        22821    (6) 8/28/2027  Class A Common Stock  22821  $0.00  97179  D   
Stock Option (Right to Buy Class A Common Stock)  $53.27  4/23/2021    M        54688    (7) 1/22/2030  Class A Common Stock  54688  $0.00  120312  D   
Stock Option (Right to Buy Class A Common Stock)  $26.27  4/26/2021    M        78334    (8) 1/30/2027  Class A Common Stock  78334  $0.00  0  D   
Stock Option (Right to Buy Class A Common Stock)  $29.31  4/26/2021    M        65929    (6) 8/28/2027  Class A Common Stock  65929  $0.00  31250  D   

Explanation of Responses:
(1)  This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
(2)  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
(3)  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.50 to $71.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
(4)  These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(5)  These options were granted on January 22, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(6)  These options were granted on August 28, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on August 28, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(7)  These options were granted on January 22, 2020, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2021, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
(8)  These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Demski David M
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON, PA 19403
X
President, CEO

Signatures
/s/ Kelly G. Huller, Attorney-in-Fact 4/27/2021
**Signature of Reporting Person Date